Global prevalence of sleep disturbances among breast cancer survivors: A systematic review with meta-analysis
Sleep Health · 2023-10 · 9 (5) · 704-716
DOI: 10.1016/j.sleh.2023.04.004 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Sleep Health, 2023-10. Verfasst von Wen Hui Cheng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Nursing Division, Singapore General Hospital, Singapore Health Services, Singapore. Hauptthemen laut MEDLINE: Breast Neoplasms, Cancer Survivors, Global Health, Sleep Wake Disorders. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 126 Literaturangaben.
Abstract (Originalsprache)
Breast cancer is a common cancer in which patients are highly susceptible to different sleep disturbances. However, current evidence lacked consistency in methodologies in investigating the prevalence of sleep disturbances among breast cancer survivors. The review aims to (1) investigate the global prevalence of sleep disturbances among breast cancer survivors; and (2) investigate the factors influencing the prevalence estimates. A comprehensive search was conducted in 8 databases using a 3-step approach, up to January 2022. The Newcastle-Ottawa Scale and Cochrane risk of bias tool were used to evaluate the quality of individual studies. Meta-analysis, meta-regression, and subgroup analysis were performed using R software. Certainty of evidence was assessed using Grading of Recommendations, Assessment, Development, and Evaluations criteria. A total of 51 studies were selected involving 28,036 breast cancer survivors across 17 countries. The global prevalence of poor sleep quality was 62%, different severities of insomnia were 3%-32%, and excessive daytime sleepiness was 24%. Subgroup analyses showed that a significantly higher prevalence of poor sleep quality was found in breast cancer survivors during treatment compared with pre- or post-treatment. No significant covariates were found in a series of meta-regression analyses. The majority (73.5%) of individual studies were high quality but the certainty of the evidence was low or very low according to Grading of Recommendations, Assessment, Development, and Evaluations criteria. More than half of breast cancer survivors have sleep disturbances, so developing a strategic intervention is warranted. Given the low or very low certainty of the evidence, a robust design for large-scale research is crucial in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Nursing Division, Singapore General Hospital, Singapore Health Services, Singapore.
- Saw Swee Hock School of Public Health, National University of Singapore, Singapore.
- Alice Lee Centre for Nursing Studies, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. Electronic address: nurly@u.nus.edu.
- Alice Lee Centre for Nursing Studies, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Zitieren
APA
Cheng, W. H., Teo, R. H., Cheng, L. J., Lau, Y., & Lau, S. T. (2023). Global prevalence of sleep disturbances among breast cancer survivors: A systematic review with meta-analysis. Sleep Health, 9(5), 704-716. https://doi.org/10.1016/j.sleh.2023.04.004
Vancouver
Cheng WH, Teo RH, Cheng LJ, Lau Y, Lau ST. Global prevalence of sleep disturbances among breast cancer survivors: A systematic review with meta-analysis. Sleep Health. 2023;9(5):704-716. doi:10.1016/j.sleh.2023.04.004
BibTeX
@article{Cheng2023,
author = {Cheng, Wen Hui and Teo, Rui Hong and Cheng, Ling Jie and Lau, Ying and Lau, Siew Tiang},
title = {Global prevalence of sleep disturbances among breast cancer survivors: A systematic review with meta-analysis},
journal = {Sleep Health},
year = {2023},
volume = {9},
number = {5},
pages = {704--716},
doi = {10.1016/j.sleh.2023.04.004}
}
EUVIMED